Search

everythinglearnresearchcommunity

for

Search:↓

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

The new adapalene formulation using TyroSpheres is more effective and less irritating for acne treatment.

Abrus precatorius has medicinal benefits but can be toxic.

Anionic squarticles can effectively counteract amitriptyline overdose, improving survival rates.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

The nanogel with Bangkal bark extract effectively fights acne-causing bacteria.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Alpha-ketoglutarate protects rabbit skin cells from oxidative damage by activating a specific cell pathway.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Ritlecitinib is safe and may effectively treat alopecia areata.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

The developed nasal gel improves cilostazol delivery to the brain, enhancing its effectiveness and reducing side effects.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.